Small-molecule transcription factor inhibitors in oncology [E-Book] / editors: Khondaker Miraz Rahman, David E. Thurston.
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be "reprogrammed", leading to apoptosis or differentiation from the malignant phenotype. As the use of kinase inhibitors is grad...
Saved in:
Full text |
|
Personal Name(s): | Rahman, Khondaker Miraz, editor |
Thurston, David E., editor | |
Imprint: |
[Cambridge] :
Royal Society of Chemistry,
[2019]
|
Physical Description: |
1 online resource (199 pages). |
ISBN: |
1782624015 9781782624011 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
RSC drug discovery series ;
65 |
Subject (LOC): |
- Synthetic Approaches and Challenges to Transcription Factor Inhibitors
- Synthetic Approaches and Challenges to Transcription Factor Inhibitors
- Natural Products as Promising Leads Against Oncogenic Transcription Factors and Associated Signalling Pathways
- Pyrrolobenzodiazepines as Transcription Factor Inhibitors: An Overview
- Small Molecule Inhibitors of NF-κB and Their Therapeutic Potential in Leukaemia
- Targeting Signal Transducer and Activator of Transcripion (STAT) 3 with Small Molecules
- Targeting Promoter G-Quadruplexes for Transcriptional Control